SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-074703
Filing Date
2011-08-09
Accepted
2011-08-09 07:01:29
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g24656ae10vq.htm 10-Q 282069
2 EX-31.1 g24656aexv31w1.htm EX-31.1 8023
3 EX-31.2 g24656aexv31w2.htm EX-31.2 8364
4 EX-32 g24656aexv32.htm EX-32 3279
  Complete submission text file 0000950123-11-074703.txt   1706427

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT pvct-20110630.xml EX-101.INS 194925
6 EX-101 SCHEMA DOCUMENT pvct-20110630.xsd EX-101.SCH 23384
7 EX-101 CALCULATION LINKBASE DOCUMENT pvct-20110630_cal.xml EX-101.CAL 35152
8 EX-101 LABELS LINKBASE DOCUMENT pvct-20110630_lab.xml EX-101.LAB 164540
9 EX-101 PRESENTATION LINKBASE DOCUMENT pvct-20110630_pre.xml EX-101.PRE 101835
10 EX-101 DEFINITION LINKBASE DOCUMENT pvct-20110630_def.xml EX-101.DEF 35713
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS PHARMACEUTICALS INC (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-09410 | Film No.: 111018876
SIC: 2834 Pharmaceutical Preparations